These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antidiabetic activity of some 1-substituted 3,5-dimethylpyrazoles. Soliman R; Darwish SA J Med Chem; 1983 Nov; 26(11):1659-63. PubMed ID: 6631920 [TBL] [Abstract][Full Text] [Related]
5. From lead to preclinical candidate: optimization of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV. Nordhoff S; López-Canet M; Hoffmann-Enger B; Bulat S; Cerezo-Gálvez S; Hill O; Rosenbaum C; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A Bioorg Med Chem Lett; 2009 Aug; 19(16):4818-23. PubMed ID: 19576767 [TBL] [Abstract][Full Text] [Related]
6. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303 [TBL] [Abstract][Full Text] [Related]
7. 55P0110, a Novel Synthetic Compound Developed from a Plant Derived Backbone Structure, Shows Promising Anti-Hyperglycaemic Activity in Mice. Brunmair B; Lehner Z; Stadlbauer K; Adorjan I; Frobel K; Scherer T; Luger A; Bauer L; Fürnsinn C PLoS One; 2015; 10(5):e0126847. PubMed ID: 25973898 [TBL] [Abstract][Full Text] [Related]
8. Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds. Momose Y; Meguro K; Ikeda H; Hatanaka C; Oi S; Sohda T Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1440-5. PubMed ID: 1934164 [TBL] [Abstract][Full Text] [Related]
9. Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats. Das KK; Razzaghi-Asl N; Tikare SN; Di Santo R; Costi R; Messore A; Pescatori L; Crucitti GC; Jargar JG; Dhundasi SA; Saso L J Enzyme Inhib Med Chem; 2016; 31(1):99-105. PubMed ID: 25683079 [TBL] [Abstract][Full Text] [Related]
10. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV). Xie M; Gao L; Li L; Liu W; Yan S J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288 [TBL] [Abstract][Full Text] [Related]
11. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents. Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060 [TBL] [Abstract][Full Text] [Related]
12. Sulfonyliminoimidazolidines. A new class of oral hypoglycemic agents. 1. 1-[[p-[2-(acylamino)ethyl]phenyl]sulfonyl]-2-iminoimidazolidines. Schweizer EH; Märki F; Lehmann C; Dietrich H J Med Chem; 1983 Jul; 26(7):964-70. PubMed ID: 6864736 [TBL] [Abstract][Full Text] [Related]
13. Preparation and antidiabetic activity of new 3-methyl-5-phenylpyrazolesulfonylurea derivatives. Soliman R; Feid-Allah HM J Pharm Sci; 1981 Jun; 70(6):602-5. PubMed ID: 6788934 [No Abstract] [Full Text] [Related]
14. Flavone-based novel antidiabetic and antidyslipidemic agents. Verma AK; Singh H; Satyanarayana M; Srivastava SP; Tiwari P; Singh AB; Dwivedi AK; Singh SK; Srivastava M; Nath C; Raghubir R; Srivastava AK; Pratap R J Med Chem; 2012 May; 55(10):4551-67. PubMed ID: 22524508 [TBL] [Abstract][Full Text] [Related]
15. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788 [TBL] [Abstract][Full Text] [Related]
16. Preparation and antidiabetic activity of new substituted 3,5-diarylpyrazolesulfonylurea derivatives. Soliman R; Feid-Allah HM; El Sadany SK; Mohamed HF J Pharm Sci; 1981 Jun; 70(6):606-10. PubMed ID: 6788935 [No Abstract] [Full Text] [Related]
17. Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a. Onda K; Suzuki T; Shiraki R; Yonetoku Y; Negoro K; Momose K; Katayama N; Orita M; Yamaguchi T; Ohta M; Tsukamoto S Bioorg Med Chem; 2008 May; 16(10):5452-64. PubMed ID: 18434170 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antidiabetic activity of some sulfonylurea derivatives of 3,4,5-trisubstituted pyrazoles. Soliman R; Mokhtar H; Mohamed HF J Pharm Sci; 1983 Sep; 72(9):1004-7. PubMed ID: 6631680 [TBL] [Abstract][Full Text] [Related]
19. Comparison on hypoglycemic and antioxidant activities of the fresh and dried Portulaca oleracea L. in insulin-resistant HepG2 cells and streptozotocin-induced C57BL/6J diabetic mice. Gu JF; Zheng ZY; Yuan JR; Zhao BJ; Wang CF; Zhang L; Xu QY; Yin GW; Feng L; Jia XB J Ethnopharmacol; 2015 Feb; 161():214-23. PubMed ID: 25523372 [TBL] [Abstract][Full Text] [Related]